Newsbenzinga
QUICK SPARK: Amgen Stock Eyes Worst Day Since October 2000
· Published
Article summary
Amgen sank 9.8% Tuesday after Novartis' pelacarsen missed its Phase 3 endpoint, casting doubt on rival Lp(a) drug olpasiran.
An excerpt from the original article.
Comments —
Loading comments…